NCT01881386View on ClinicalTrials.gov

Lactate Imaging as a Tumour Biomarker

CompletedOBSERVATIONAL

Enrollment

37

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

September 1, 2017

Study Completion Date

September 1, 2017

Conditions

Cancer

Interventions

DEVICE

Magnetic Resonance Imaging (MRI)

Magnetic Resonance Spectroscopy

Trial Locations (1)

SM2 5PT

The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton

Sponsors

Collaborators (1)

Cancer Research UK

All Listed Sponsors

collaborator

Cancer Research UK

OTHER

lead

Institute of Cancer Research, United Kingdom

OTHER